CATHERINE CANNAN: Open Payments
NPI 1740821115 · PLAINVILLE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 34 payments from 15 companies in 2025. Trend: 2023 $720 · 2024 $196 · 2025 $1,027
Food & beverage: $912Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 4 | $115 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| GENZYME CORPORATION | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 3 | $90 |
| ARRAY BIOPHARMA INC | 4 | $89 |
| Celgene Corporation | 3 | $88 |
| PFIZER INC. | 4 | $62 |
| ABBVIE INC. | 2 | $55 |
| Genentech USA, Inc. | 2 | $54 |
Products named: SYNCHROMEDII, TALVEY, SARCLISA, OPDUALAG, REBLOZYL, BRAFTOVI, IMFINZI, TAGRISSO.
Industry payments across CT — which companies pay providers there.
